Pharmacological treatment of obesity in clinical practice

Medicine Science

Ibrahim Sahin¹  Omercan Topaloglu² 

[1] Inonu University Medical Faculty Department of Endocrinology and Metabolism;Zonguldak Bulent Ecevit University Medical Faculty, Department of Endocrinology and Metabolism;

关键词: obesity;    pharmacological treatment;    obesity treatment;    liraglutide;    orlistat;   

DOI  :  10.5455/medscience.2021.05.151

来源: DOAJ

【 摘 要 】

Anti-obesity medications may be considered in the subjects with BMI ≥30 kg/m2, or with BMI 27-29.9 kg/m2 and weight-related comorbidities, whom weight reduction is not achieved via lifestyle modifications alone. If weight loss is inadequate ( [Med-Science 2021; 10(2.000): 651-7]

【 授权许可】

Unknown